Cargando…

Targeting MAPK in Cancer 2.0

Detalles Bibliográficos
Autores principales: Rovida, Elisabetta, Tusa, Ignazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143559/
https://www.ncbi.nlm.nih.gov/pubmed/35628511
http://dx.doi.org/10.3390/ijms23105702
_version_ 1784715835805270016
author Rovida, Elisabetta
Tusa, Ignazia
author_facet Rovida, Elisabetta
Tusa, Ignazia
author_sort Rovida, Elisabetta
collection PubMed
description
format Online
Article
Text
id pubmed-9143559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91435592022-05-29 Targeting MAPK in Cancer 2.0 Rovida, Elisabetta Tusa, Ignazia Int J Mol Sci Editorial MDPI 2022-05-20 /pmc/articles/PMC9143559/ /pubmed/35628511 http://dx.doi.org/10.3390/ijms23105702 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Rovida, Elisabetta
Tusa, Ignazia
Targeting MAPK in Cancer 2.0
title Targeting MAPK in Cancer 2.0
title_full Targeting MAPK in Cancer 2.0
title_fullStr Targeting MAPK in Cancer 2.0
title_full_unstemmed Targeting MAPK in Cancer 2.0
title_short Targeting MAPK in Cancer 2.0
title_sort targeting mapk in cancer 2.0
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143559/
https://www.ncbi.nlm.nih.gov/pubmed/35628511
http://dx.doi.org/10.3390/ijms23105702
work_keys_str_mv AT rovidaelisabetta targetingmapkincancer20
AT tusaignazia targetingmapkincancer20